VEDUShchIE ENDOKRINOLOGI OBSUDILI MESTO NOVOGO PREPARATA FORSIGA™ V LEChENII SAKhARNOGO DIABETA 2 TIPA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

- -

References

  1. Инструкция по медицинскому применению лекарственного препарата Форсига™ (таблетки, покрытые пленочной оболочкой, 5 и 10 мг). Регистрационное удостоверение ЛС - 002596 от 21.08.2014.
  2. DF Diabetes Atlas. 6th ed. 2013.
  3. Narayan K.M., Boyle J.P., Thompson T.J., Sorensen S.W., Williamson D.F. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003; 290( 14):1884-90.
  4. Langkilde A.M., et al. Presented at the 49th Annual Meeting of the EASD, Barcelona, Spain, 23-27 September, 2013:Abstract 936.
  5. www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002322/human_med_001546.jsp&mid
  6. www.fda.gov/newsevents/newsroom/pressannouncements/ucm380829.htm

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies